Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826605 · ClinicalTrials.gov registry record
Urobilinogen, Maternal Weight Loss and Impending Parturition at Term
A clinical trial, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- 200
- Enrollment target
NCT00826605 is a clinical trial that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 200 participants.
The verdict
NCT00826605 has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study, then, is to search existing clinic and hospital records for answers to the following two questions: (1) Do pregnant women who are at least 37 weeks gestation and who have an increase in urubilinogen on urine dipstick at a prenatal appointment have a statistically significant shorter average time before going into active labor than their negative counterparts? (2) Do pregnant women who are at least 37 weeks gestation and who show a modest weight loss between two prenatal appointments have a statistically significant shorter average time before going into active labor than their counterparts who did not lose weight?
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826605
The ClinicalTrials.gov registry entry for NCT00826605 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University Center for Health Sciences, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00826605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00826605 about?
NCT00826605 is a clinical study titled "Urobilinogen, Maternal Weight Loss and Impending Parturition at Term". The purpose of this study, then, is to search existing clinic and hospital records for answers to the following two questions: (1) Do pregnant women who are at least 37 weeks gestation and who have an increase in urubilinogen on urine dipstick at a prenatal appointment have a statistically significa...
What is the current status of trial NCT00826605?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2009-01. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00826605?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.